Hydrocortisone Export Market Intelligence: India's 597 Suppliers Shipping to 156 Countries — TransData Nexus 2026

Q: Who are the top hydrocortisone exporters from India?

The top hydrocortisone exporters from India are: 1. STRIDES PHARMA SCIENCE LIMITED — $9.1M (13.9% market share); 2. LINCOLN PHARMACEUTICALS LTD — $5.4M (8.2% market share); 3. CIPLA LIMITED — $3.6M (5.4% market share); 4. CIRON DRUGS AND PHARMACEUTICALS PRIVATE LIMITED — $3.1M (4.7% market share); 5. MACLEODS PHARMACEUTICALS LTD — $2.6M (3.9% market share). Together they account for 36.1% of India's total hydrocortisone export value.

Q: What is the total export value of hydrocortisone from India?

The total export value of hydrocortisone from India is $65.7M USD, recorded across 6,743 shipment transactions from 597 active exporters to 156 destination countries. The average shipment value is $9.7K.

Q: Which countries import hydrocortisone from India?

India exports hydrocortisone to 156 countries worldwide. The top importing countries are: UNITED STATES (23.0% share, $15.1M), TANZANIA (9.7% share, $6.4M), AUSTRALIA (4.4% share, $2.9M), KENYA (4.0% share, $2.6M), SOUTH AFRICA (3.7% share, $2.4M). These five markets account for 44.8% of total export value.

Q: What is the average price of hydrocortisone exports from India?

The average unit price for hydrocortisone exports from India is $10.11 USD per unit, with prices ranging from $0.00 to $7566.25 depending on formulation, packaging, and order volume. The total market is valued at $65.7M across 6,743 shipments.

Q: Which ports handle hydrocortisone exports from India?

The primary ports for hydrocortisone exports from India are SAHAR AIR (13.1% of shipments), SAHAR AIR CARGO ACC (INBOM4) (12.3% of shipments), NHAVA SHEVA SEA (INNSA1) (10.0% of shipments), DELHI AIR CARGO ACC (INDEL4) (7.6% of shipments), DELHI AIR (6.3% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of hydrocortisone?

India is one of the world's leading exporters of hydrocortisone due to its large base of 597 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports hydrocortisone to 156 countries, demonstrating 80% global market coverage.

Q: What certifications do Indian hydrocortisone exporters need?

Indian hydrocortisone exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import hydrocortisone from India?

There are 1,716 registered buyers importing hydrocortisone from India, spread across 156 countries. The repeat buyer rate is 46.4%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top hydrocortisone supplier from India?

STRIDES PHARMA SCIENCE LIMITED is the leading hydrocortisone exporter from India with a market share of 13.9% and total export value of $9.1M across 115 shipments. The top 5 suppliers together control 36.1% of total export value.

Suresh Sormare

Hydrocortisone

India Pharmaceutical Trade Intelligence

$65.7M597 Suppliers156 CountriesHS 30049099

ExportsIndia → UNITED STATES23.0%India → TANZANIA9.7%

ImportsUNITED STATES → India$1.0M FRANCE → India$246.6K

#1 Supplier: STRIDES PHARMA #1 Buyer: STRIDES PHARMA

Hydrocortisone Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Hydrocortisone to the World

Between 2022 and 2026, India exported $65.7M worth of hydrocortisone across 6,743 verified shipments to 156 countries — covering 80% of world markets in the Corticosteroids segment. The largest destination is UNITED STATES (23.0%). STRIDES PHARMA SCIENCE LIMITED leads with a 13.9% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Hydrocortisone export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Hydrocortisone export data snapshot — $65.7M · 597 exporters · 156 countriesTransData Nexus · Indian Customs Data

Top Hydrocortisone Exporters from India

597 active exporters · Ranked by export value

View all 597 →

Top Hydrocortisone Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	STRIDES PHARMA SCIENCE LIMITED	$9.1M	115	2	13.9%
2	LINCOLN PHARMACEUTICALS LTD

Top Countries Importing Hydrocortisone from India

156 destination markets · Ranked by import value

All 156 countries →

Top Countries Importing Hydrocortisone from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	UNITED STATES	$15.1M	23.0%
2	TANZANIA	$6.4M	9.7%
3	AUSTRALIA	$2.9M	4.4%
4	KENYA	$2.6M	4.0%
5	SOUTH AFRICA	$2.4M	3.7%
6	PHILIPPINES	$2.2M	3.4%
7	UNITED ARAB EMIRATES	$2.0M	3.1%
8	TURKEY	$1.6M	2.4%
9	IRAQ	$1.5M	2.3%
10	UNITED KINGDOM	$1.5M	2.2%

UNITED STATES is India's largest hydrocortisone export destination, absorbing 23.0% of total exports worth $15.1M. The top 5 importing countries — UNITED STATES, TANZANIA, AUSTRALIA, KENYA, SOUTH AFRICA — together account for 44.8% of India's total hydrocortisone export value. The remaining 151 destination countries collectively receive the other 55.2%, indicating a well-diversified global distribution network spanning all major continents.

Who Supplies Hydrocortisone to India?

15 origin countries · Total import value: $1.3M

India imports hydrocortisone from 15 countries with a combined import value of $1.3M. The largest supplier is UNITED STATES ($1.0M, 117 shipments), followed by FRANCE and IRAQ. All values are from Indian Customs (DGFT) import records.

Countries Supplying Hydrocortisone to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	UNITED STATES	$1.0M	117	78.6%
2	FRANCE	$246.6K	6	19.2%
3	IRAQ	$7.5K	1	0.6%
4	GERMANY	$5.6K	8	0.4%
5	IRELAND	$3.5K	1	0.3%
6	BELGIUM	$3.3K	9	0.3%
7	CANADA	$2.4K	3	0.2%
8	UNITED KINGDOM	$1.9K	15	0.1%
9	GREECE	$1.6K	1	0.1%
10	SINGAPORE	$716	50	0.1%

Showing top 10 of 15 origin countries

UNITED STATES is the largest supplier of hydrocortisone to India, accounting for 78.6% of total import value. The top 5 origin countries — UNITED STATES, FRANCE, IRAQ, GERMANY, IRELAND — together supply 99.2% of India's hydrocortisone imports. Click any country to see detailed supplier and buyer data for that import corridor.

Hydrocortisone — Export Intelligence Video

Visual overview of India's hydrocortisone import and export market — top suppliers, destinations, pricing, and trade routes

This video covers India's hydrocortisone pharmaceutical import and export market — $65.7M in total trade, 597 verified manufacturers, and 156 destination countries. Data sourced from Indian Customs (DGFT) shipment records.

Regulatory Landscape — Hydrocortisone

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

In the United States, hydrocortisone is approved for various indications, including adrenal insufficiency and inflammatory conditions. The FDA's Orange Book lists multiple approved Abbreviated New Drug Applications (ANDAs) for hydrocortisone formulations, reflecting a competitive generic market. Notably, on September 29, 2020, the FDA approved ALKINDI® SPRINKLE, a hydrocortisone formulation indicated as replacement therapy in pediatric patients with adrenocortical insufficiency.

The substantial number of Indian exporters (597) underscores India's significant role in supplying hydrocortisone to the U.S. market. However, exporters must navigate the FDA's stringent regulatory framework, including compliance with Current Good Manufacturing Practices (cGMP) and potential import alerts. As of March 2026, there are no active FDA import alerts specifically targeting hydrocortisone products from India, indicating a favorable compliance status.

2EU & UK Regulatory Framework

In the European Union, hydrocortisone is subject to the European Medicines Agency's (EMA) marketing authorization process. For instance, Efmody, a hydrocortisone formulation, received a positive opinion from the EMA's Committee for Medicinal Products for Human Use (CHMP) on January 29, 2026, recommending its use for the treatment of adrenal insufficiency and congenital adrenal hyperplasia in adolescents aged 12 years and over and adults. (ema.europa.eu)

The United Kingdom, post-Brexit, maintains its own regulatory framework through the Medicines and Healthcare products Regulatory Agency (MHRA). Hydrocortisone products require MHRA approval, adhering to standards analogous to those of the EMA. Compliance with EU Good Manufacturing Practice (GMP) guidelines is mandatory for manufacturing facilities supplying these markets.

3WHO Essential Medicines & Global Standards

Hydrocortisone is included in the World Health Organization's (WHO) Model List of Essential Medicines, underscoring its critical role in healthcare systems worldwide. The WHO Prequalification Programme evaluates medicines like hydrocortisone to ensure they meet global standards of quality, safety, and efficacy. Additionally, hydrocortisone formulations are standardized in various pharmacopoeias, including the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), ensuring consistent quality across different markets.

4India Regulatory Classification

In India, hydrocortisone is classified under Schedule H of the Drugs and Cosmetics Act, indicating that it is a prescription-only medication. The National Pharmaceutical Pricing Authority (NPPA) regulates the pricing of essential medicines; however, as of March 2026, hydrocortisone is not listed under the Drug Price Control Order (DPCO), allowing market-driven pricing. Exporters must obtain a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT) for the export of pharmaceutical products, ensuring compliance with national regulations.

5Patent & Exclusivity Status

Hydrocortisone, being an established pharmaceutical compound, is generally off-patent, facilitating the production and export of generic formulations. This lack of patent protection has led to a competitive market with multiple manufacturers and suppliers, both domestically and internationally.

6Recent Industry Developments

In September 2025, Laboratoire Aguettant withdrew its application for marketing authorization of Hydrocortisone Aguettant, intended for the prevention of bronchopulmonary dysplasia in preterm infants, following feedback from the EMA indicating that the benefits did not outweigh the risks. (ema.europa.eu)

On January 29, 2026, the EMA's CHMP adopted a positive opinion recommending a change to the terms of the marketing authorization for Efmody, expanding its indication to include the treatment of adrenal insufficiency in adolescents aged 12 years and over and adults. (ema.europa.eu)

In June 2025, the EMA published a list of nationally authorized medicinal products containing hydrocortisone, following a periodic safety update report single assessment (PSUSA/00010855/202408), ensuring continued pharmacovigilance and safety monitoring. (ema.europa.eu)

These developments highlight the dynamic regulatory landscape surrounding hydrocortisone, emphasizing the importance of continuous monitoring and compliance for stakeholders involved in its production and distribution.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Supply Chain Risk Assessment — Hydrocortisone

API sourcing, concentration risk, storage requirements, and current alerts

MEDIUM RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry, often referred to as the "pharmacy of the world," heavily relies on China for Active Pharmaceutical Ingredients (APIs) and Key Starting Materials (KSMs). Approximately 70% of APIs used in Indian drug manufacturing are imported from China. This dependency poses significant risks, as evidenced during the COVID-19 pandemic when Chinese factory shutdowns led to immediate shortages and price surges for essential drugs.

To mitigate this vulnerability, the Indian government has initiated the Production Linked Incentive (PLI) scheme, aiming to bolster domestic API and KSM production. In October 2024, two greenfield plants were inaugurated under this scheme to manufacture critical molecules like Penicillin G and Clavulanic Acid, which had not been produced domestically for over two decades. These efforts are part of a broader strategy to reduce import dependence by half for essential pharmaceutical ingredients.

2Supplier Concentration & Single-Source Risk

The export market for hydrocortisone from India is moderately concentrated, with the top five exporters accounting for 36.1% of total exports. STRIDES PHARMA SCIENCE LIMITED leads with a 13.9% share, followed by LINCOLN PHARMACEUTICALS LTD at 8.2%. While this concentration indicates a degree of diversification, the reliance on a limited number of suppliers still presents a risk. Any operational disruptions among these key players could significantly impact the global supply chain.

Access Complete Hydrocortisone Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 6,743 transactions across 156 markets.

Request Demo View Pricing

Frequently Asked Questions — Hydrocortisone Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top hydrocortisone exporters from India?

The leading hydrocortisone exporters from India are STRIDES PHARMA SCIENCE LIMITED, LINCOLN PHARMACEUTICALS LTD, CIPLA LIMITED, and 12 others. STRIDES PHARMA SCIENCE LIMITED leads with 13.9% market share ($9.1M). The top 5 suppliers together control 36.1% of total export value.

What is the total export value of hydrocortisone from India?

The total export value of hydrocortisone from India is $65.7M, recorded across 6,743 shipments from 597 active exporters to 156 countries. The average shipment value is $9.7K.

Which countries import hydrocortisone from India?

India exports hydrocortisone to 156 countries. The top importing countries are UNITED STATES (23.0%), TANZANIA (9.7%), AUSTRALIA (4.4%), KENYA (4.0%), SOUTH AFRICA (3.7%), which together account for 44.8% of total export value.

What is the HS code for hydrocortisone exports from India?

The primary HS code for hydrocortisone exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Hydrocortisone

Hydrocortisone

How India Exports Hydrocortisone to the World

Top Hydrocortisone Exporters from India

Top Countries Importing Hydrocortisone from India

Who Supplies Hydrocortisone to India?

Quick Facts

Related Corticosteroids

Related Analysis

Need Details?

Hydrocortisone — Export Intelligence Video

Regulatory Landscape — Hydrocortisone

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Supply Chain Risk Assessment — Hydrocortisone

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Hydrocortisone Trade Intelligence

Frequently Asked Questions — Hydrocortisone Exports from India

Who are the top hydrocortisone exporters from India?

What is the total export value of hydrocortisone from India?

Which countries import hydrocortisone from India?

What is the HS code for hydrocortisone exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of hydrocortisone exports from India?

Which ports handle hydrocortisone exports from India?

Why is India a leading exporter of hydrocortisone?

What certifications do Indian hydrocortisone exporters need?

How many buyers import hydrocortisone from India?

What is the market share of the top hydrocortisone exporter from India?

Analysis Methodology